Analysis of the Global Diabetes Drug Delivery Market

Analysis of the Global Diabetes Drug Delivery Market

Future Options for End Users

RELEASE DATE
17-Mar-2015
REGION
Global
Research Code: P85B-01-00-00-00
SKU: LS00146-GL-MR_16987
AvailableYesPDF Download
$4,950.00
In stock
SKU
LS00146-GL-MR_16987
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and European diabetes markets. Depending on end-user acceptability of inhalable diabetes drugs, the global diabetes market can expect an increase in future investments. With the exception of one approved inhalable drug delivery system, there are no other inhalable products in the diabetes clinical pipeline at present.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Key Findings—Options in the Global Diabetes Drug Delivery Market

Unmet Needs in the Diabetes Drug Delivery Market

Pumps or Pens—Future Investment Opportunities for Type 1 Diabetes

Scope and Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

3 Key Predictions

Market Background

Market Segmentation

Market Segmentation (continued)

Global Diabetes Drug Delivery Market—Type of Delivery Usage by Region

New Market Opportunities

New Market Opportunities (continued)

Pipeline of Diabetes Drug Delivery Systems

Attractiveness in Diabetes Drug Delivery Market

Market Engineering Measurements

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Type of Diabetes Drug Delivery

Revenue Forecast Discussion

Top Competitors

Market Engineering Measurements

Injectable Diabetes Drug Delivery Market—Revenue Forecast

Revenue Forecast Discussion

Injectable Diabetes Drug Delivery Market—Competitive Assessment

Promising Injectable—Once-a-week Diabetes Drug

Market Engineering Measurements

Oral Diabetes (Non-insulin) Drug Delivery Market—Revenue Forecast

Revenue Forecast Discussion

Oral Diabetes Drug Delivery Market—Competitive Assessment

Market Engineering Measurements

Inhalable Diabetes Drug Delivery Market—Revenue Forecast

Inhalable Diabetes Drug Delivery Market—Competitive Assessment

Inhalable Drug Delivery System and Injectable Drug Delivery System

The United States—New Technologies in Diabetes Drug Delivery

The United States—Trends in Diabetes Drug Delivery

Europe—New Technologies in Diabetes Drug Delivery

Europe—Trends in Diabetes Drug Delivery

APAC (India)—New Technologies in Diabetes Drug Delivery

APAC (India)—Trends in Diabetes Drug Delivery Market

Becton Dickinson and Company

Gerresheimer Bünde

Owen Mumford Ltd

Zosano Pharma Corporation

ViaCyte, Inc.

Echo Therapeutics

Conclusion

Frost & Sullivan Awards

Legal Disclaimer

Market Engineering Methodology

Drivers Explained

Drivers Explained (continued)

Restraints Explained

Learn More—Next Steps

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and European diabetes markets. Depending on end-user acceptability of inhalable diabetes drugs, the global diabetes market can expect an increase in future investments. With the exception of one approved inhalable drug delivery system, there are no other inhalable products in the diabetes clinical pipeline at present.
More Information
No Index No
Podcast No
Author Siddharth Dutta
WIP Number P85B-01-00-00-00
Is Prebook No